Clinical Trial

Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test

New assays for ketamine and tramadol testing pass initial Intelligent Fingerprinting design phase and begin next stage of transfer to…

11 months ago

Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine

Published Phase 2 Study findings demonstrate safety and efficacy of idrevloride in hypertonic saline for treatment of primary ciliary dyskinesiaAbstract…

11 months ago

BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease

--Site activation allows for patients in the State of New York to participate in the BRTX-100 trial— --15 Clinical Sites…

11 months ago

CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology

BERKELEY HEIGHTS, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

11 months ago

Spectral Medical Featured in New Episode of ‘The Balancing Act’ Airing on Lifetime TV Focused on Endotoxic Septic Shock

Episode to be Broadcast on Monday, September 11th and Tuesday, September 19th 2023 at 7:30 a.m. (ET/PT) TORONTO, Sept. 08,…

11 months ago

Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs

Two best-in-class lung imaging companies combine expertise for the deployment of a new xenon 129 MRI platform.Durham, NC and London,…

11 months ago

Rhythm Pharmaceuticals Announces Update to September Conference Participation

BOSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…

11 months ago

MMJ Positioned To Win DEA Lawsuit As HHS Verifies Marijuana Has Medical Benefit To Patients

Marijuana DeScheduling News Much To Do Over NothingWASHINGTON D.C. / ACCESSWIRE / September 8, 2023 / Attorney Megan Sheehan representing…

11 months ago

Skye Bioscience Reverse Stock Split to Be Effective on September 8th

San Diego, California--(Newsfile Corp. - September 7, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a pharmaceutical company developing proprietary…

11 months ago